Naloxone spray
·
3 Min Read

Biden administration boosts access to overdose prevention, treatment

The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.

Behavioral Health
Man in a mask, in a prison cell
·
5 Min Read

Why denying addiction treatment in jails, prisons is inhumane

Evidence shows medications to treat substance-use disorder treatment in jails and prisons are lifesaving, yet they’re too often denied. Learn more with the AMA.

Population Health
Stethoscope on a clipboard with a hand using a computer mouse
·
5 Min Read

What we need to advance equity: reflection, partnership, accountability

With new plan, the AMA will use its resources and influence to help dismantle structural racism and work toward a more equitable future for all people.

series
Leadership
Leadership Viewpoints
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases
·
8 Min Read

AMA in the News: April 2021

Read media highlights mentioning the American Medical Association for April 2021.

series
AMA in the News
AMA in the News
·
1 Min Read

AMA statement on HHS decision to remove addiction treatment barriers

AMA is pleased that HHS will support physicians to prescribe buprenorphine, will remove daunting regulatory barriers for patients with opioid use disorder.

Press Releases
Conversation with two people in a health care office
·
3 Min Read

Texas FQHC develops integrative model to help patients with pain

Austin clinic developed a comprehensive, integrative pain-management program to support patients’ comprehensive needs.

Behavioral Health
·
2 Min Read

AMA statement on JAMA podcast and tweet

Recent podcast and tweet published by JAMA inconsistent with the policies and views of AMA.

Press Releases
·
4 Min Read

Feb. 5, 2021: National Advocacy Update

Expanding patients’ access to buprenorphine and more in the latest National Advocacy Update.

Advocacy Update